SYNOVIAL SARCOMA
Clinical trials for SYNOVIAL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMA trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer patients get chance to continue promising drug in Long-Term safety study
Disease control CompletedThis study allowed patients with various cancers who had benefited from the drug tazemetostat in earlier trials to continue receiving it. The main goal was to monitor the drug's long-term safety in these patients. It was open to people who had not seen their cancer worsen and cou…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists hunt for clues to match sarcoma patients with treatment
Knowledge-focused CompletedThis study aimed to find biological markers that could predict which patients with advanced soft-tissue sarcoma would respond well to the drug trabectedin. Researchers collected tumor and blood samples from 29 adult patients before, during, and after treatment to analyze their ge…
Matched conditions: SYNOVIAL SARCOMA
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC